Biofrontera (BFRI) Interest & Investment Income (2023 - 2025)
Biofrontera (BFRI) recorded quarterly Interest & Investment Income of -$121000.0 in Q4 2025, down 9.01% quarter-over-quarter from -$111000.0 in Q3 2025, and down 202.5% on a YoY basis from $118048.8 in Q4 2024.
Biofrontera (BFRI) Interest & Investment Income (2023 - 2025) Analysis & Trends
Biofrontera's Interest & Investment Income history runs 3 years deep, the most recent figure standing at -$121000.0 for Q4 2025.
- In Q4 2025, Interest & Investment Income fell 202.5% year-over-year to -$121000.0; the TTM figure through Dec 2025 stood at -$453000.0 (up 77.74% YoY), while the FY2025 annual figure was -$452000.0, up 77.79% from the prior year.
- Interest & Investment Income was -$121000.0 for Q4 2025 at Biofrontera, down from -$111000.0 in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $56000.0 in Q1 2023 to a low of -$1.4 million in Q1 2024.
- Historically, Interest & Investment Income has averaged -$259250.0 across 3 years, with a median of -$113000.0 in 2025.
- Biggest YoY gain for Interest & Investment Income was 105.63% in 2024; the steepest drop was 2612.5% in 2024.
- A 3-year view of Interest & Investment Income shows it stood at -$579000.0 in 2023, then soared by 93.09% to -$40000.0 in 2024, then sank by 202.5% to -$121000.0 in 2025.
- The last three Interest & Investment Income figures came in at -$121000.0 (Q4 2025), -$111000.0 (Q3 2025), and -$115000.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | 41.80 Mn |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | 3.45 Mn |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | 28.10 Mn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | 8.54 Mn |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | 4.97 Mn |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | - |
| 10 | Biofrontera | 8.97 Mn | 2.56 Mn | 14.09 Mn | -121,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -121,000.00 |
| Sep 30, 2025 | -111,000.00 |
| Jun 30, 2025 | -115,000.00 |
| Mar 31, 2025 | -106,000.00 |
| Dec 31, 2024 | -40,000.00 |
| Sep 30, 2024 | 8,000.00 |
| Jun 30, 2024 | -596,000.00 |
| Mar 31, 2024 | -1.41 Mn |
| Dec 31, 2023 | -579,000.00 |
| Sep 30, 2023 | -142,000.00 |
| Jun 30, 2023 | 42,000.00 |
| Mar 31, 2023 | 56,000.00 |